ONLINE DATABASE SEARCH - OI-LS-381-MEMO
1. 61500 OI-LS-381; SCIFINDER-OI-8/13/2007
Thuggacins, macrolide antibiotics active against Mycobacterium tuberculosis: isolation from myxobacteria, structure elucidation, conformation analysis and biosynthesis
Steinmetz, Heinrich, Irschik, Herbert, Kunze, Brigitte, Reichenbach, Hans, Hoefle, Gerhard, and Jansen, Rolf
Chem.--Eur. J. 2007. 13(20): 5822-5832
2. 61501 OI-LS-381; SCIFINDER-OI-8/13/2007
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps
Amaral, Leonard, Martins, Marta, and Viveiros, Miguel
J. Antimicrob. Chemother. 2007. 59(6): 1237-1246
3. 61502 OI-LS-381; WOS-OI-8/10/2007
Synthesis of Putative Chain Terminators of Mycobacterial Arabinan Biosynthesis
Smellie, I. et al.
Organic & Biomolecular Chemistry 2007. 5(14): 2257-2266
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247768900023
4. 61503 OI-LS-381; SCIFINDER-OI-8/13/2007
Efficacy of clarithromycin on Mycobacterium avium which proliferates in bronchial epithelial cells
Yamazaki, Yoshitaka
Jpn. J. Antibiot. 2007. 60(Suppl. A): 28-31
5. 61504 OI-LS-381; WOS-OI-8/10/2007
New Anti-Tuberculosis Therapies
Portero, J. and Rubio, M.
Expert Opinion on Therapeutic Patents 2007. 17(6): 617-637
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247719900003
6. 61505 OI-LS-381; SCIFINDER-OI-8/13/2007
IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy
Roque Susana, Nobrega Claudia, Appelberg Rui, and Correia-Neves Margarida
J Immunol 2007. 178(12): 8028-35.
7. 61506 OI-LS-381; SCIFINDER-OI-8/13/2007
Invasion and Egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs
Lavine, MD and Arrizabalaga, G
Curr. Pharm. Des. 2007. 13(6): 641-651
8. 61507 OI-LS-381; SCIFINDER-OI-8/13/2007
Coordination to copper(II) strongly enhances the in vitro antimicrobial activity of pyridine-derived N(4)-tolyl thiosemicarbazones
Mendes, Isolda C, Moreira, Juliana P, Mangrich, Antonio S, Balena, Solange P, Rodrigues, Bernardo L, and Beraldo, Heloisa
Polyhedron 2007. 26(13): 3263-3270
9. 61508 OI-LS-381; SCIFINDER-OI-8/13/2007
Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L
Reddy, Muntha K, Gupta, Sashi K, Jacob, Melissa R, Khan, Shabana I, and Ferreira, Daneel
Planta Med. 2007. 73(5): 461-467
10. 61509 OI-LS-381; SCIFINDER-OI-8/13/2007
Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
Uyama, Hirokazu, Nakamura, Hideji, Hayashi, Eijiro, Ogawa, Hiroyuki, Enomoto, Hirayuki, Yoshida, Kenya, Okuda, Yorihide, Yamamoto, Mitsunari, Hada, Toshikazu, and Hayashi, Norio
Hepatol. Res. 2007. 37(5): 325-330
11. 61510 OI-LS-381; SCIFINDER-OI-8/13/2007
Preparation of azacytosine acyclic nucleotide derivatives useful as antiviral agents
Holy, Antonin, Krecmerova, Marcela, Piskala, Alois, Andrei, Graciela, Snoeck, Robert, De Clercq, Erik, Neyts, Johan, and Naesens, Lieve
PATENT: WO 2007065231 ISSUE DATE: 20070614
APPLICATION: 2006 PP: 96pp.
ASSIGNEE: (K.U. Leuven Research & Development, Belg. and Institute of Organic Chemistry and Biochemistry of Academy of Sciences of the Czech Republic)
12. 61511 OI-LS-381; SCIFINDER-OI-8/13/2007
Mechanism of drug-resistance in human cytomegalovirus
Eizuru Yoshito
Nippon Rinsho 2007. 65 Suppl 2 Pt. 1: 476-9.
13. 61512 OI-LS-381; SCIFINDER-OI-8/13/2007
Antivirals for herpesviruses and cytomegalovirus
Minematsu Toshio
Nippon Rinsho 2007. 65 Suppl 2 Pt. 1: 396-400.
14. 61513 OI-LS-381; SCIFINDER-OI-8/13/2007
Structural characterization and antifungal studies of some mixed ligand schiff base complexes with 6-bromo-2-thio 3-phenyl quinazoline-4(3H) one thiosemicarbazone
Rai, BK, Choudhary, Pramod, Rana, Sweta, and Sahi, Poonam
Orient. J. Chem. 2007. 23(1): 271-275
15. 61514 OI-LS-381; WOS-OI-8/17/2007
Therapeutic Efficacy of Posaconazole Against Isolates of Candida Albicans With Different Susceptibilities to Fluconazole in a Vaginal Model
Gonzalez, G. et al.
Medical Mycology 2007. 45(3): 221-224
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247374400004
16. 61515 OI-LS-381; WOS-OI-8/17/2007
Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors
Pauwels, F. et al.
Journal of Virology 2007. 81(13): 6909-6919
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247404900014
17. 61516 OI-LS-381; SCIFINDER-OI-8/13/2007
Synthesis and antimicrobial activity of some novel 2-(4-substituted-phenyl)-5- (naphthalen-1-yloxy-methyl) [1,3,4] oxadiazoles and 1-[2-(4-substituted phenyl)-5-(naphthaten-1- yloxy-methyl)-[1,3,4]oxadiazol-3-yl]-ethanones
Rajak, Harish, Kharya, Murlidhar, and Mishra, Pradeep
Int. J. Chem. Sci. 2007. 5(1): 365-379
18. 61517 OI-LS-381; WOS-OI-8/17/2007
Synthesis of Methylene-Bridged Analogues of Biologically Active Pteridine Derivatives
Slusarczyk, M. et al.
European Journal of Organic Chemistry 2007.(18): 2987-2994
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247799200011
19. 61518 OI-LS-381; WOS-OI-8/17/2007
Hts, Chemical Hybridization, and Drug Design Identify a Chemically Unique Antituberculosis Agent-Coupling Serendipity and Rational Approaches to Drug Discovery
Mao, J. et al.
Chemmedchem 2007. 2(6): 811-813
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247392900008
20. 61519 OI-LS-381; PUBMED-OI-8/20/2007
Characterization of the metabolic activation of a HCV nucleoside inhibitor beta -D-2'-deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species
Ma, H, Jiang, WR, Robledo, N, Leveque, V, Ali, S, Lara-Jaime, T, Masjedizadeh, M, Smith, DB, Cammack, N, Klumpp, K, and Symons, J
J Biol Chem 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17698842&dopt=abstract
21. 61520 OI-LS-381; PUBMED-OI-8/20/2007
Synthesis and Enzyme Inhibitory Activity of the S-Nucleoside Analogue of the Ribitylaminopyrimidine Substrate of Lumazine Synthase and Product of Riboflavin Synthase
Talukdar, A, Illarionov, B, Bacher, A, Fischer, M, and Cushman, M
J Org Chem 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17696548&dopt=abstract
22. 61521 OI-LS-381; PUBMED-OI-8/20/2007
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by Novel Dideoxy Nucleosides
Rai, D, Johar, M, Srivastav, NC, Manning, T, Agrawal, B, Kunimoto, DY, and Kumar, R
J Med Chem 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17696514&dopt=abstract
23. 61522 OI-LS-381; PUBMED-OI-8/20/2007
Identification of Inhibitors for Mycobacterial Protein Tyrosine Phosphatase B (MptpB) by Biology-Oriented Synthesis (BIOS)
Correa, IR Jr, Noren-Muller, A, Ambrosi, HD, Jakupovic, S, Saxena, K, Schwalbe, H, Kaiser, M, and Waldmann, H
Chem Asian J 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17685373&dopt=abstract
24. 61523 OI-LS-381; PUBMED-OI-8/20/2007
Design, Synthesis, and Pharmacological Evaluation of Mefloquine-Based Ligands as Novel Antituberculosis Agents
Mao, J, Wang, Y, Wan, B, Kozikowski, AP, and Franzblau, SG
ChemMedChem 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17680579&dopt=abstract
25. 61524 OI-LS-381; PUBMED-OI-8/20/2007
Chemoenzymatic synthesis of feruloyl D: -arabinose as a potential anti-mycobacterial agent
Vafiadi, C, Topakas, E, Alderwick, LJ, Besra, GS, and Christakopoulos, P
Biotechnol Lett 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17676274&dopt=abstract
26. 61525 OI-LS-381; PUBMED-OI-8/20/2007
Morphine Inhibits Intrahepatic Interferon- alpha Expression and Enhances Complete Hepatitis C Virus Replication
Li, Y, Ye, L, Peng, JS, Wang, CQ, Luo, GX, Zhang, T, Wan, Q, and Ho, WZ
J Infect Dis 2007. 196(5): 719-30
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17674315&dopt=abstract
27. 61526 OI-LS-381; PUBMED-OI-8/20/2007
Antifungal potential of disulfiram
Khan, S, Singhal, S, Mathur, T, Upadhyay, DJ, and Rattan, A
Nippon Ishinkin Gakkai Zasshi 2007. 48(3): 109-13
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17667894&dopt=abstract
28. 61527 OI-LS-381; PUBMED-OI-8/20/2007
Identification and characterization of an aspartyl protease from Cryptococcus neoformans
Pinti, M, Orsi, CF, Gibellini, L, Esposito, R, Cossarizza, A, Blasi, E, Peppoloni, S, and Mussini, C
FEBS Lett 2007. 581(20): 3882-6
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17651737&dopt=abstract
29. 61528 OI-LS-381; PUBMED-OI-8/20/2007
Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells
Johann, S, Soldi, C, Lyon, JP, Pizzolatti, MG, and Resende, MA
Lett Appl Microbiol 2007. 45(2): 148-53
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17651210&dopt=abstract